INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2004

Oral aloe vera gel increased clinical response in mildly to moderately active ulcerative colitis.

Forty-four outpatients with active ulcerative colitis were randomized to receive 100 mL oral aloe vera gel or placebo twice daily for four weeks. Clinical response occurred in 47% (14 of 30) of patients receiving aloe vera compared to 14% (2 of 14) given placebo (p < 0.05; odds ratio 5.3, 95% CI 1.0-27). Aloe vera significantly reduced clinical colitis activity (p = 0.01) and histological scores (p = 0.03), while sigmoidoscopic scores and adverse events did not differ between groups.

Study type
Randomized controlled trial
Who was studied
44 hospital outpatients with active ulcerative colitis
What was measured
Clinical, sigmoidoscopic, and histological remission

THE PAPER

Randomized, double-blind, placebo-controlled trial of oral aloe vera gel for active ulcerative colitis.

Langmead L, Feakins RM, Goldthorpe S, Holt H, Tsironi E, De Silva A, Jewell DP, Rampton DS. Aliment Pharmacol Ther, 2004.

PubMed 15043514 ↗DOI 10.1111/j.1365-2036.2004.01902.x ↗

Gut & microbiome

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.